Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)
Clinical trial NCT04268472 · COMPLETED
Trial details
- NCT number
- NCT04268472
- Sponsor
- Geropharm
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-06
- Primary completion
- 2019-09-06
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.